https://www.indianpharmapost.com/qiagen-and-gt-molecular-collaborate-to-detect-sars-cov-2-in-wastewater-99592021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/krishna-institute-of-medical-sciences-pat-at-rs-8912-cr-for-q1fy22-99732021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/sequent-scientific-net-profit-at-rs-8730-lakh-in-q1fy22-99722021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-posts-net-profit-of-rs-54246-cr-in-q1fy22-99712021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/marksons-pharma-pat-at-rs-626-cr-for-q1fy22-99702021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/cadila-healthcare-net-profit-at-rs-5872-cr-in-q1fy22-99692021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/gw-pharmaceuticals-receives-approval-for-epidyolex-to-treat-seizures-99682021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsk-files-application-for-mmr-vaccine-in-the-us-99672021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/penpulimab-monoclonal-antibody-pd-1-obtains-marketing-approval-in-china-99662021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/global-healthcare-supply-chain-management-market-to-reach-us-36-billion-by-2026-99652021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/tesis-labs-and-personal-genome-diagnostics-tie-up-to-advance-cancer-treatment-99642021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/pear-therapeutics-three-fda-authorised-prescriptions-available-at-optumrx-99632021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/moderna-to-set-up-mrna-manufacturing-in-canada-99622021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/fujifilm-irvine-scientific-appointed-global-distributor-of-presagens-life-whisperer-99612021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/new-cap-guideline-improves-diagnoses-of-patients-with-monoclonal-gammopathies-99602021-08-11T00:00:00+05:30always0.9https://www.indianpharmapost.com/nppa-has-put-a-cap-on-the-trade-margin-of-42-select-non-scheduled-anti-cancer-medicines-99742021-08-11T00:00:00+05:30always0.9